Clopidogrel Viatris 75 mg film-coated tablets

DRUG4 trials

Sponsors

St Antonius Hospital, Stichting Radboud universitair medisch centrum, Centre Hospitalier Universite De Laval, Fondation Hopital Saint Joseph

Conditions

Atrial Fibrillation Device thrombosis post-Left Atrial Appendage ClosureAtrial fibrillation Acute coronary syndrome Chronic coronary syndromeCLTI defined as Rutherford category 4 or 5Stroke

Phase 3

Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia after Distal Revascularization: a randomized, double-blind trial PALADIN [PeripherAL Arterial DIsease Network] -DAPTCLTI

Not yet recruitingCTIS2025-524297-42-00

Fondation Hopital Saint JosephCLTI defined as Rutherford category 4 or 5

Target: 614Updated: 2026-03-05

Phase 4

What is the optimal antithrombotic strategy in patients with atrial fibrillation having acute coronary syndrome or undergoing percutaneous coronary intervention?

RecruitingCTIS2022-502140-13-00

St Antonius HospitalAtrial fibrillation Acute coronary syndrome Chronic coronary syndrome

Start: 2023-01-11Target: 3000Updated: 2026-01-26

Stopping or continuing platelet inhibitors after cryptogenic stroke at young age: STOP trial

RecruitingCTIS2024-513092-40-00

Stichting Radboud universitair medisch centrumStroke

Start: 2024-12-05Target: 1316Updated: 2025-08-06

Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES study.

Not yet recruitingCTIS2025-520954-12-00

Centre Hospitalier Universite De LavalAtrial Fibrillation Device thrombosis post-Left Atrial Appendage Closure

Target: 250Updated: 2025-02-03